Harvard Bioscience Inc. (HBIO) - Prakiraan pendapatan perusahaan

Harvard Bioscience (HBIO) partially relies on external component suppliers, focusing on final high-precision assembly. Projected sales revenue demonstrates a trend in inflows, where the current status is 0.09. Revenue stability is ensured by consistent demand for equipment from universities. Meanwhile, moderate pricing power is limited by budget cuts among US biotech startups, which constrains the growth of instrument costs.

Harvard Bioscience - Prakiraan volume dodolan HBIO (periode 04.07.2022 - 13.11.2026)

Ringkesan rincian data analitis Harvard Bioscience Inc. (HBIO)

- rega saiki lan proyeksi nilai saham:

Kutipan saham Harvard Bioscience, Inc.|HBIO - Rega prakiraan analis

- indikator kapitalisasi pasar:

Nilai pasar Harvard Bioscience Inc.|HBIO - Nilai Dipunlarasaken Utang lan Kas

- data ekuitas miturut neraca:

Nilai Akuntansi saben Saham Harvard Bioscience|HBIO - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku harvardbioscience.com|HBIO - Gunggung Aset Perusahaan

- indikator beban utang lan likuiditas:

Total Utang marang Modal Harvard Bioscience|HBIO - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Harvard Bioscience|HBIO - Utang agregat perusahaan|Utang marang nilai buku Harvard Bioscience Inc.|HBIO - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Harvard Bioscience|Rasio cepet harvardbioscience.com

- rincian asil keuangan lan kelipatan valuasi:

HBIO - Bathi pungkasan|Proyeksi bathi mangsa ngarep Harvard Bioscience|HBIO - Pangali P/E|Rega marang bathi mangsa ngarep Harvard Bioscience, Inc.|HBIO - Koefisien bali modal nimbang wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Harvard Bioscience Inc.|HBIO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Harvard Bioscience|HBIO - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan harvardbioscience.com|HBIO - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Harvard Bioscience

- indikator volume dodolan lan pendapatan:

HBIO - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Harvard Bioscience|HBIO - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S Harvard Bioscience Inc.

Ringkesan analitik perusahaan:Harvard Bioscience, Inc. HBIO

The f_sales_co metric serves as a leading indicator of fundamental stability, assessing the expected revenue of the company. The calculation is based on the daily aggregation of market expectations, which eliminates the time lag associated with standard financial reporting. Analyzing the organization's prospective sales allows for the timely detection of shifts in long-term trends. For Harvard Bioscience (HBIO), the metric's dynamics reflect the efficiency of outsourcing production and services to third-party contractors. This enables investors to evaluate the scalability of the business model through the lens of future cash flows.

Pesaing wigati